Per Multiple Sclerosis News Today, "Treatment with Ocrevus (ocrelizumab) has superior or comparable effectiveness and a similar safety profile to other available disease-modifying treatments (DMTs) for treating relapsing multiple sclerosis (MS), according to a new review study."
Ocrevus has superior or comparable effec... - My MSAA Community
Ocrevus has superior or comparable effectiveness and a similar safety profile to other available DMTs for RRMS
Written by
sashaming1
To view profiles and participate in discussions please or .
Read more about...
1 Reply
•
I saw this article and since I’m on Ocrevus thought 👍👍👍 but I also read that 3 of the 6 authors worked for Genentech/Roche. So a bit of a conflict of interest 🤷♀️
Not what you're looking for?
You may also like...
Obesity at Young Age Ups Multiple Sclerosis Risk
Both childhood and adolescent obesity are linked to an increased risk for multiple sclerosis,...
Blood Test for MS Activity Gets FDA Breakthrough Designation
The US Food and Drug Administration (FDA) has granted breakthrough device designation to the...
Challenging Times - Our Voices Must Be Heard!
Many of you are connected with the National Multiple Sclerosis Society and may even get involved...
UdeM researchers find molecule to block multiple sclerosis progression
A team of researchers at the Université de Montréal has identified a potential drug target that...
If our wish came true.....
